5.1 Chemical Peel Depths, Acid Formulations & Master Esthetician Solutions

5.1 Chemical Peel Depths, Acid Formulations & Master Esthetician Solutions

Independent study guide by OpenExamPrep. Chemical peeling—also termed chemexfoliation or chemical resurfacing—is the controlled application of chemical exfoliating agents to the cutaneous surface to produce structured partial-thickness tissue injury, epidermal shedding, and subsequent dermal wound healing with de novo neocollagenesis. In clinical master esthetics, chemical peeling represents one of the most potent, versatile non-surgical interventions for treating solar elastosis, rhytids, dyschromia, melasma, actinic damage, and acne vulgaris.

The clinical efficacy and therapeutic safety of any chemical peel depend entirely on the anatomical depth of cutaneous penetration and coagulative necrosis. In Washington, RCW 18.16.020 allows estheticians to use superficial and light peels and adds the performance of medium depth peels to master esthetics. The statute does not define these depths, so exam questions use the professional classification below, in which medium-depth peels reach the papillary dermis and upper reticular dermis. Understanding peel depths, acid pharmacology, biochemical mechanisms of action, and systemic contraindications is essential for passing the Washington Master Esthetician examination and maintaining clinical safety.

---

Anatomical Depth Classification Architecture

Chemical peels are categorized clinically and histologically into four distinct anatomical tiers based on the deepest cutaneous layer reached by the chemexfoliant. This classification determines healing time, clinical indications, anesthesia requirements, and regulatory boundaries.

Cutaneous Cross-Section & Chemical Peel Penetration Depths:

┌────────────────────────────────────────┐ ◄── Surface / Stratum Corneum
│ 1. VERY SUPERFICIAL PEEL               │     Depth: Stratum Corneum (0.01–0.02 mm)
├────────────────────────────────────────┤ ◄── Stratum Granulosum / Spinosum
│ 2. SUPERFICIAL PEEL                    │     Depth: Full Epidermis to Basal Layer (0.06–0.1 mm)
├════════════════════════════════════════┤ ◄── Dermal-Epidermal Junction (DEJ) / Basement Membrane
│ 3. MEDIUM-DEPTH PEEL                   │     Depth: Necrosis of Entire Epidermis,
│    (Upper Limit of Master Esthetics)   │     Papillary Dermis into Upper Reticular Dermis (0.2–0.45 mm)
├────────────────────────────────────────┤ ◄── Upper Reticular Dermis
│ 4. DEEP PEEL                           │     Depth: Mid-to-Deep Reticular Dermis (0.6–0.8 mm)
│    (Physician Procedure)               │     Phenol / Baker-Gordon Formula — Outside Esthetics Scopes
└────────────────────────────────────────┘ ◄── Subcutaneous Hypodermis

1. Very Superficial Chemical Peels

• Target Histological Layer: Confined strictly to the stratum corneum (the outermost cornified anucleated layer of the epidermis) and uppermost stratum granulosum.
• Depth of Injury: 0.01 to 0.02 mm.
• Biochemical Formulations: Low-concentration alpha-hydroxy acids (AHAs, such as glycolic acid 10–20% or lactic acid 10–20%), low-concentration beta-hydroxy acids (salicylic acid 10–20%), and proteolytic botanical enzyme formulations (papain from papaya, bromelain from pineapple, pancreatin, or pumpkin ferment).
• Mechanism of Action: Enzymes hydrolyze peptide bonds between structural proteins of dead corneocytes. Low-strength AHAs decrease calcium ion concentration in desmosomal junctions, weakening intercellular cohesion and accelerating epidermal transit.
• Clinical Indications: Mild surface xerosis, dull sallow complexion, rough skin texture, maintenance between aggressive clinical modalities, and superficial epidermal stratum corneum thinning.
• Downtime and Healing: Zero true clinical downtime. Erythema resolves within 1 to 4 hours; microscopic flaking may occur over 2 to 3 days without visible sheet desquamation.

2. Superficial Chemical Peels

• Target Histological Layer: Extends through the viable epidermal layers (stratum spinosum) down to the stratum basale (basal layer), immediately superior to the dermal-epidermal junction (DEJ).
• Depth of Injury: 0.06 to 0.1 mm.
• Biochemical Formulations: High-concentration AHAs (Glycolic acid 30–50%, Lactic acid 40–50%, Mandelic acid 30–40%), Salicylic acid 20–30%, Jessner's solution applied in 1 to 3 coats, and low-strength Trichloroacetic acid (TCA 10–15%).
• Mechanism of Action: AHAs induce epidermal epidermolysis and cellular detachments; salicylic acid provides lipophilic keratolysis and sebaceous comedolysis; low-dose TCA produces light focal superficial protein coagulation.
• Clinical Indications: Active comedonal and Grade I–II papular acne, mild post-inflammatory hyperpigmentation (PIH), superficial solar lentigines, fine epidermal micro-rhytids, and epidermal melasma.
• Downtime and Healing: 3 to 7 days. Mild-to-moderate erythema followed by light, bran-like epidermal flaking or mild peeling. Does not breach the basement membrane; zero risk of true structural dermal scarring when unmanipulated.

3. Medium-Depth Chemical Peels

• Target Histological Layer: Produces complete coagulative necrosis through the entire epidermis, breaches the basement membrane zone (dermal-epidermal junction), traverses the papillary dermis, and extends into the upper reticular dermis.
• Depth of Injury: 0.2 to 0.45 mm.
• Biochemical Formulations: Trichloroacetic acid (TCA) 35%, combination Jessner's solution + 35% TCA (Monheit technique), combination 70% glycolic acid + 35% TCA (Coleman technique), or combination solid carbon dioxide (CO2) + 35% TCA (Brody technique).
• Mechanism of Action: Full-thickness epidermal destruction triggers an intense acute inflammatory response within the vascular papillary dermis. Cytokines, basic fibroblast growth factor (bFGF), and transforming growth factor-beta (TGF-β) stimulate dermal fibroblasts to synthesize Type III collagen, subsequently maturing into organized Type I collagen parallel to the skin surface, alongside dermal ground substance (glycosaminoglycans) and elastic fibers.
• Clinical Indications: Actinic keratoses (pre-cancerous epidermal lesions), moderate photoaging, diffuse solar lentigines, solar elastosis, moderate perioral and periorbital rhytids, and superficial distensible acne scarring.
• Downtime and Healing: 7 to 14 days. Intense erythema, heavy edema, marked Level II to Level III clinical frosting, followed by browning, crusting, and sheet-like epidermal desquamation. Complete re-epithelialization occurs from surviving epithelial appendages (hair follicles, sebaceous glands, eccrine ducts) in 7 to 10 days.
• Regulatory Authorization: RCW 18.16.020(32) includes the performance of medium depth peels in the practice of master esthetics.

4. Deep Chemical Peels

• Target Histological Layer: Extends into the mid-to-deep reticular dermis (0.6 to 0.8 mm).
• Biochemical Formulations: Phenol-based formulations, historically and clinically epitomized by the Baker-Gordon formula (USP 88% Phenol, croton oil, Septisol liquid soap, and distilled water).
• Mechanism of Action: Uncontrolled, rapid, irreversible protein coagulation and total destruction of the reticular dermal architecture down to the mid-reticular stratum, inducing severe wound contracture, permanent dermal collagen remodeling, and massive neocollagenesis.
• Clinical Indications: Severe photoaging (Glogau Class IV), deep furrowed rhytids, severe solar elastosis, and profound perioral "smoker's" lines.
• Downtime and Healing: 14 to 28 days of weeping re-epithelialization, followed by persistent erythema lasting 3 to 6 months. Produces permanent hypopigmentation ("porcelain skin"), line of demarcation, and total loss of cutaneous melanocyte function.
• Scope of Practice Restriction: Deep peels go beyond the medium depth peels named in RCW 18.16.020 and are performed by physicians.

---

Chemical Peel Depth Classification & Comparative Metrics

The following table outlines the diagnostic parameters, target histology, active formulations, and regulatory scopes across all chemical peel tiers:

---

Jessner's Classic Formulation: Biochemistry & Pharmacology

Formulated by dermatologist Dr. Max Jessner to minimize the toxicity of individual ingredients while exploiting their therapeutic synergy, Jessner's solution is a classic combination agent widely employed in clinical master esthetics.

Chemical Composition of Classic Jessner's Solution

Classic Jessner's solution contains three active chemexfoliating agents dissolved in a high-purity ethanol vehicle:

Classic Jessner's Solution Formulation:
├── 14% Resorcinol (USP)
├── 14% Salicylic Acid (USP)
├── 14% Lactic Acid (USP 85%)
└── Dissolved in 95% Ethanol solvent vehicle (q.s. 100 mL)

• Resorcinol (14%): A crystalline dihydroxybenzene phenol derivative (C6H6O2) structurally related to phenol and catechol. Resorcinol disrupts weak hydrogen bonds within keratin, functioning as a potent keratolytic agent that induces desquamation. Clinical Precaution: Resorcinol is transdermally absorbed. High systemic concentrations can inhibit thyroid peroxidase, suppressing thyroid hormone synthesis and potentially triggering transient myxedema, contact dermatitis, or central nervous system toxicity in susceptible individuals.
• Salicylic Acid (14%): A beta-hydroxy acid (ortho-hydroxybenzoic acid) characterized by lipophilic aromatic ring structure. It selectively dissolves intercellular lipid bilayers cemented between stratum corneum corneocytes, penetrates deep into sebum-filled pilosebaceous follicles, and exerts anti-inflammatory, antimicrobial, and comedolytic effects.
• Lactic Acid (14%): An alpha-hydroxy acid (2-hydroxypropanoic acid) that weakens ionic desmosomal bonds between epidermal keratinocytes, accelerates desquamation, and simultaneously functions as an intrinsic physiological humectant by stimulating natural moisturizing factor (NMF) synthesis.
• 95% Ethanol: Functions as a fast-evaporating solvent vehicle that thoroughly degreases the cutaneous surface, ensures rapid drying, and facilitates deep, uniform penetration of the active compounds.

Application Dynamics & Depth Control

Jessner's solution is a coat-dependent, self-limiting peel. The depth of penetration correlates directly with the number of anatomical coats applied:

• 1 to 2 Coats: Produces very superficial to superficial exfoliation with mild erythema and faint patchy white salt precipitation or Level I frosting.
• 3 to 4 Coats: Penetrates to the basal layer of the epidermis, producing moderate erythema and Level I to early Level II frosting.
• 5+ Coats: Can achieve deep epidermal necrosis. However, applying more than 3 coats increases the risk of resorcinol-induced contact sensitization and post-inflammatory hyperpigmentation, particularly in Fitzpatrick Phototypes IV–VI.

---

Trichloroacetic Acid (TCA): Keratocoagulation & Biochemistry

Trichloroacetic Acid (CCl3COOH) is a chlorinated analogue of acetic acid synthesized by the chlorination of acetic acid where three hydrogen atoms of the methyl group are replaced by chlorine atoms. In clinical skincare, TCA is the gold standard medium-depth peeling agent.

Mechanism of Action: Keratocoagulation & Protein Denaturation

Unlike alpha-hydroxy acids, which act biochemically by disrupting calcium-mediated desmosomal cadherins, TCA acts through non-enzymatic protein denaturation and keratocoagulation:

1. Upon topical application, TCA donates hydronium ions to keratin and structural cellular proteins.
2. The severe alteration in tissue pH causes proteins to lose their tertiary and secondary structural conformations, precipitating out of solution.
3. This keratocoagulation manifests clinically as an immediate, opaque white frost. The frost consists of physically coagulated, necrotic epidermal and dermal proteins.
4. Keratocoagulation creates a self-limiting biological barrier: the coagulated protein layer resists further acid diffusion, preventing uncontrolled deeper penetration into underlying tissues.

Systemic Safety of TCA

A major clinical advantage of trichloroacetic acid over phenol is that it is not associated with systemic toxicity at peel concentrations:

• TCA is bound to epidermal and dermal proteins at the site of contact as it coagulates them.
• It is not absorbed in clinically significant amounts.
• TCA peels are not associated with the cardiac, liver, or kidney toxicity seen with phenol.

Unbuffered vs. Buffered TCA Formulations

• Unbuffered Aqueous TCA: Mixed strictly by weight-to-volume ratio (w/v, e.g., 35 grams of USP TCA crystals dissolved in distilled water up to 100 mL). It exhibits a very low pH (often < 1.0) and delivers rapid, aggressive protein coagulation. In clinical esthetics, standard clinical studies and classical medical literature refer exclusively to unbuffered aqueous formulations.
• Buffered / Compounded TCA: Formulated with buffering salts, oils, or surfactant emulsions to raise the pH slightly or retard cutaneous evaporation. Buffered formulations slow down penetration, offering a milder sensation but making the precise assessment of clinical depth and frosting endpoints more difficult to calibrate.

---

Advanced Combination Medium-Depth Protocols

Historically, attempting to achieve medium-depth resurfacing using trichloroacetic acid alone required high concentrations of 50% TCA. However, 50% TCA causes unpredictable dermal penetration, uneven scattering, severe risk of follicular destruction, persistent hypertrophic scarring, and irreversible dyschromia. To solve this clinical challenge, pioneering dermatologists developed combination protocols utilizing a superficial prep agent to breach the stratum corneum barrier, followed by 35% TCA to produce smooth, uniform papillary dermal necrosis.

1. The Monheit Technique (Jessner's Solution + 35% TCA)

Developed by Dr. Gary Monheit, this is the most widely practiced medium-depth peel protocol in advanced clinical aesthetics:

• Step 1: Classic Jessner's solution is applied in 1 to 2 uniform coats across the entire treatment field.
• Histological Role: Jessner's solution dissolves intercellular lipids, exfoliates the stratum corneum, and disrupts the epidermal barrier.
• Step 2: 35% unbuffered Trichloroacetic acid is applied evenly using cotton-tipped applicators or gauze pads.
• Clinical Result: Because the epidermal barrier was evenly compromised by Jessner's, the 35% TCA penetrates uniformly across the entire anatomical zone, achieving a consistent Level II to Level III frosting extending into the papillary dermis without focal pooling, hot spots, or the catastrophic scarring risks of 50% TCA.

2. The Coleman Technique (70% Glycolic Acid + 35% TCA)

Described by Dr. William Coleman III and Dr. John Futrell:

• Step 1: 70% unbuffered glycolic acid is applied to the face and allowed to dwell for precisely 2 minutes to induce acute epidermolysis.
• Step 2: The glycolic acid is completely neutralized with a saturated sodium bicarbonate (NaHCO3) solution, rinsed with water, and dried thoroughly.
• Step 3: 35% TCA is applied immediately.
• Clinical Result: Similar to the Monheit protocol, the glycolic acid pre-treatment strips the stratum corneum barrier, permitting 35% TCA to achieve controlled, uniform papillary dermal penetration.

3. The Brody Technique (Solid CO2 + 35% TCA)

Developed by Dr. Harold Brody:

• Step 1: A block of solid carbon dioxide (dry ice, -78.5°C) dipped in acetone and alcohol is rolled lightly over the cutaneous surface to freeze the epidermis.
• Step 2: 35% TCA is applied immediately.
• Clinical Result: The thermal freeze damages keratinocyte cell membranes, allowing rapid, uniform penetration of the 35% TCA into the papillary dermis.

---

Deep Chemical Peeling: Phenol Biochemistry & Systemic Toxicity

Deep chemical peeling utilizes Phenol (C6H5OH, carbolic acid), most notably in the Baker-Gordon formula (1961):

Baker-Gordon Deep Phenol Formula:
├── 3.0 mL USP 88% Liquid Phenol
├── 2.1 mL Distilled Water
├── 8 drops Septisol (liquid hexachlorophene soap / surfactant)
└── 3 drops Croton Oil (from Croton tiglium seed)

• Croton Oil: The critical active biological driver; croton oil contains phorbol esters that cause profound dermal blistering, severe inflammation, and reticular dermal collagen liquefaction. Without croton oil, pure phenol penetrates poorly and produces only superficial-to-medium necrosis.
• Septisol: Acts as a surfactant and surface-tension-reducing agent, dispersing the hydrophobic croton oil evenly throughout the aqueous phenol solution.